IMPACT Trial: Intervention to iMProve AdherenCe Equitably
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT05496829
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Multicomponent Adherence Intervention — BEHAVIORALThe adherence intervention will be comprised of a participant preference approach in which all participants undergo a baseline pharmacist-led medication optimization session and are offered training in how to use the patient portal and freely-available smartphone reminder app.
- Usual Care — OTHERReceipt of usual care from providers
Study Details
To determine the efficacy of a multicomponent adherence intervention among participants with early-stage breast cancer on endocrine therapy and at least one oral cardiovascular disease (CVD) medication on adherence to endocrine therapy and to CVD medication at 24 weeks assessed by self-report using the Domains of Subjective Extent (DOSE)-Nonadherence questionnaire and also by pharmacy fill data assessed in the electronic health record (EHR).
Key Dates
- Start date
- Mar 2, 2023
- Status verified
- May 2026
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 350 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Adherence InterventionMulticomponent Adherence Intervention
- Other: Usual CareUsual Care from treating providers
Primary Outcome Measure
Number of Participants Adherent to Endocrine Therapy (ET) and CVD Medication at 24 Weeks [ Time Frame: 24 Weeks ]
Central Contacts
- Research Nurse Navigator212-342-5162
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Medical Center | New York | New York | 10032 | Dawn Hershman, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By condition
By specialty
By research site
Related Studies
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey